AptarGroup (ATR) 10-Q 6 Nov 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Nov. 03, 2014
Document and Entity Information	'	'
Entity Registrant Name	'APTARGROUP INC	'
Entity Central Index Key	'0000896622	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Entity Current Reporting Status	'Yes	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	64,727,773
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
CONDENSED CONSOLIDATED STATEMENTS OF INCOME	'	'	'	'
Net Sales	$651,942	$623,644	$1,998,624	$1,882,718
Operating Expenses:	'	'	'	'
Cost of sales (exclusive of depreciation and amortization shown below)	443,520	424,011	1,347,982	1,273,848
Selling, research & development and administrative	91,649	86,917	294,809	269,335
Depreciation and amortization	38,158	37,222	113,871	112,007
Restructuring initiatives	'	2,180	'	8,758
Total Operating Expenses	573,327	550,330	1,756,662	1,663,948
Operating Income	78,615	73,314	241,962	218,770
Other Income (Expense):	'	'	'	'
Interest expense	-5,332	-4,841	-15,459	-15,364
Interest income	1,386	576	3,449	2,271
Equity results of affiliates	-124	-286	-1,868	-609
Miscellaneous, net	-429	-437	-582	-1,070
Total Other Income (Expense)	-4,499	-4,988	-14,460	-14,772
Income before Income Taxes	74,116	68,326	227,502	203,998
Provision for Income Taxes	25,496	23,094	77,390	68,908
Net Income	48,620	45,232	150,112	135,090
Net (Income) Loss Attributable to Noncontrolling Interests	-25	32	-52	5
Net Income Attributable to AptarGroup, Inc.	$48,595	$45,264	$150,060	$135,095
Net Income Attributable to AptarGroup, Inc. per Common Share:	'	'	'	'
Basic (in dollars per share)	$0.75	$0.68	$2.30	$2.04
Diluted (in dollars per share)	$0.73	$0.67	$2.21	$1.98
Average Number of Shares Outstanding:	'	'	'	'
Basic (in shares)	64,886	66,092	65,225	66,222
Diluted (in shares)	66,845	67,986	67,761	68,273
Dividends per Common Share (in dollars per share)	$0.28	$0.25	$0.81	$0.75

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME 10Q (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME	'	'	'	'
Net Income	$48,620	$45,232	$150,112	$135,090
Other Comprehensive Income:	'	'	'	'
Foreign currency translation adjustments	-118,758	45,344	-123,359	16,282
Changes in treasury locks, net of tax	6	9	18	39
Defined benefit pension plan, net of tax	'	'	'	'
Amortization of prior service cost included in net income, net of tax	51	61	157	183
Amortization of net loss included in net income, net of tax	658	1,039	1,987	3,111
Total defined benefit pension plan, net of tax	709	1,100	2,144	3,294
Total other comprehensive (loss) income	-118,043	46,453	-121,197	19,615
Comprehensive (Loss) Income	-69,423	91,685	28,915	154,705
Comprehensive (Income) Loss Attributable to Noncontrolling Interests	-29	30	-47	-2
Comprehensive (Loss) Income Attributable To AptarGroup, Inc.	($69,452)	$91,715	$28,868	$154,703

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current Assets:	'	'
Cash and equivalents	$347,394	$309,861
Accounts and notes receivable, less allowance for doubtful accounts of $4,215 in 2014 and $4,416 in 2013	468,182	438,221
Inventories	340,952	353,159
Prepaid and other	102,644	97,170
Total Current Assets	1,259,172	1,198,411
Property, Plant and Equipment:	'	'
Buildings and improvements	362,485	377,300
Machinery and equipment	1,951,876	1,982,195
Property, Plant and Equipment, Gross	2,314,361	2,359,495
Less: Accumulated depreciation	-1,505,822	-1,518,894
Property, Plant and Equipment, Net	808,539	840,601
Land	22,475	24,061
Total Property, Plant and Equipment	831,014	864,662
Other Assets:	'	'
Investments in affiliates	6,053	8,243
Goodwill	339,275	358,865
Intangible assets, net	42,551	49,951
Miscellaneous	21,174	17,630
Total Other Assets	409,053	434,689
Total Assets	2,499,239	2,497,762
Current Liabilities:	'	'
Notes payable	243,983	138,445
Current maturities of long-term obligations	2,547	1,325
Accounts payable and accrued liabilities	385,343	403,051
Total Current Liabilities	631,873	542,821
Long-Term Obligations	355,583	354,814
Deferred Liabilities and Other:	'	'
Deferred income taxes	29,501	42,072
Retirement and deferred compensation plans	66,545	71,883
Deferred and other non-current liabilities	4,859	5,864
Commitments and contingencies	'	'
Total Deferred Liabilities and Other	100,905	119,819
AptarGroup, Inc. stockholders' equity	'	'
Common stock, $.01 par value, 199 million shares authorized, 86.0 and 85.4 million shares issued as of September 30, 2014 and December 31, 2013, respectively	859	853
Capital in excess of par value	539,055	493,947
Retained earnings	1,716,536	1,619,419
Accumulated other comprehensive (loss) income	-11,441	109,751
Less: Treasury stock at cost, 21.3 and 20.0 million shares as of September 30, 2014 and December 31, 2013, respectively	-834,729	-744,213
Total AptarGroup, Inc. Stockholders' Equity	1,410,280	1,479,757
Noncontrolling interests in subsidiaries	598	551
Total Stockholders' Equity	1,410,878	1,480,308
Total Liabilities and Stockholders' Equity	$2,499,239	$2,497,762

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, except Share data in Millions, unless otherwise specified
CONDENSED CONSOLIDATED BALANCE SHEETS	'	'
Accounts and notes receivable, allowance for doubtful accounts (in dollars)	$4,215	$4,416
Common stock, par value (in dollars per share)	$0.01	$0.01
Common stock, shares authorized	199	199
Common stock, shares issued	86	85.4
Treasury stock, shares	21.3	20

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (USD $)	Retained Earnings	Accumulated Other Comprehensive Income/(Loss)	Common Stock Par Value	Treasury Stock	Capital in Excess of Par Value	Non-Controlling Interest	Total
In Thousands, unless otherwise specified
Balance at Dec. 31, 2012	$1,513,558	$60,683	$840	($625,401)	$430,210	$608	$1,380,498
Increase (Decrease) in Stockholders' Equity	'	'	'	'	'	'	'
Net income (loss)	135,095	'	'	'	'	-5	135,090
Foreign currency translation adjustments	'	16,275	'	'	'	7	16,282
Changes in unrecognized pension gains/losses and related amortization, net of tax	'	3,294	'	'	'	'	3,294
Changes in treasury locks, net of tax	'	39	'	'	'	'	39
Stock option exercises & restricted stock vestings	'	'	12	1	55,523	'	55,536
Cash dividends declared on common stock	-49,674	'	'	'	'	'	-49,674
Treasury stock purchased	'	'	'	-80,222	'	'	-80,222
Balance at Sep. 30, 2013	1,598,979	80,291	852	-705,622	485,733	610	1,460,843
Balance at Dec. 31, 2013	1,619,419	109,751	853	-744,213	493,947	551	1,480,308
Increase (Decrease) in Stockholders' Equity	'	'	'	'	'	'	'
Net income (loss)	150,060	'	'	'	'	52	150,112
Foreign currency translation adjustments	'	-123,354	'	'	'	-5	-123,359
Changes in unrecognized pension gains/losses and related amortization, net of tax	'	2,144	'	'	'	'	2,144
Changes in treasury locks, net of tax	'	18	'	'	'	'	18
Stock option exercises & restricted stock vestings	'	'	6	1	45,108	'	45,115
Cash dividends declared on common stock	-52,943	'	'	'	'	'	-52,943
Treasury stock purchased	'	'	'	-90,517	'	'	-90,517
Balance at Sep. 30, 2014	$1,716,536	($11,441)	$859	($834,729)	$539,055	$598	$1,410,878

CONDENSED_CONSOLIDATED_STATEME3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Cash Flows from Operating Activities:	'	'
Net income	$150,112	$135,090
Adjustments to reconcile net income to net cash provided by operations:	'	'
Depreciation	109,821	108,259
Amortization	4,050	3,748
Stock based compensation	15,025	11,538
Provision for doubtful accounts	228	-516
Deferred income taxes	-12,701	-5,612
Defined benefit plan expense	12,622	14,531
Equity in results of affiliates in excess of cash distributions received	1,868	609
Changes in balance sheet items, excluding effects from foreign currency adjustments:	'	'
Accounts receivable	-57,220	-42,531
Inventories	-11,386	-27,168
Prepaid and other current assets	-14,984	-15,416
Accounts payable and accrued liabilities	5,236	8,544
Income taxes payable	-13,334	10,312
Retirement and deferred compensation plans	-9,803	-18,717
Other changes, net	20,426	11,850
Net Cash Provided by Operations	199,960	194,521
Cash Flows from Investing Activities:	'	'
Capital expenditures	-125,465	-110,350
Disposition of property and equipment	1,002	2,207
Investment in unconsolidated affiliate	'	-13
Notes receivable, net	-2,820	-159
Net Cash Used by Investing Activities	-127,283	-108,315
Cash Flows from Financing Activities:	'	'
Proceeds from notes payable	106,455	31,908
Proceeds from long-term obligations	2,816	'
Repayments of long-term obligations	'	-25,491
Dividends paid	-52,943	-49,674
Credit facility costs	-299	-498
Proceeds from stock option exercises	24,564	38,368
Purchase of treasury stock	-90,517	-80,222
Excess tax benefit from exercise of stock options	4,959	5,058
Net Cash Used by Financing Activities	-4,965	-80,551
Effect of Exchange Rate Changes on Cash	-30,179	12,441
Net Increase in Cash and Equivalents	37,533	18,096
Cash and Equivalents at Beginning of Period	309,861	229,755
Cash and Equivalents at End of Period	$347,394	$247,851

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	BASIS OF PRESENTATION
	The accompanying Unaudited Condensed Consolidated Financial Statements include the accounts of AptarGroup, Inc. and our subsidiaries.  The terms “AptarGroup” or “Company” as used herein refer to AptarGroup, Inc. and our subsidiaries.  All significant intercompany accounts and transactions have been eliminated.
	In the opinion of management, the Unaudited Condensed Consolidated Financial Statements include all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of consolidated financial position, results of operations, comprehensive income, changes in equity and cash flows for the interim periods presented.  The accompanying Unaudited Condensed Consolidated Financial Statements have been prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”).  Certain information and footnote disclosure normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures made are adequate to make the information presented not misleading.  Also, certain financial position data included herein was derived from the Audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013 but does not include all disclosures required by GAAP.  Accordingly, these Unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with the Audited Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.  The results of operations of any interim period are not necessarily indicative of the results that may be expected for the year.
	ADOPTION OF RECENT ACCOUNTING PRONOUNCEMENTS
	Changes to GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of accounting standards updates to the FASB’s Accounting Standards Codification.
	In July 2013, the FASB issued authoritative guidance on the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists.  This standard requires an entity to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward.  The guidance is effective for the Company’s fiscal years beginning after December 15, 2013.  This standard did not impact our current year financial statements as this was already the Company’s existing reporting treatment.
	In March 2013, the FASB issued authoritative guidance which permits an entity to release cumulative translation adjustments into net income when a reporting entity (parent) ceases to have a controlling financial interest in a subsidiary or group of assets that is a business within a foreign entity.  Accordingly, the cumulative translation adjustment should be released into net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided, or if a controlling financial interest is no longer held. The guidance is effective for the Company’s fiscal years beginning after December 15, 2013.  This standard has only a minimal impact on our current year financial statements.
	In February 2013, the FASB issued authoritative guidance that amends the presentation of accumulated other comprehensive income and clarifies how to report the effect of significant reclassifications out of accumulated other comprehensive income.  The guidance requires footnote disclosures regarding the changes in accumulated other comprehensive income by component and the line items affected in the statements of earnings.  The adoption of this standard had no impact on the Unaudited Condensed Consolidated Financial Statements other than disclosure.  Additional information can be found in Note 6 of the Unaudited Notes to the Condensed Consolidated Financial Statements.
	In January 2013, the FASB issued authoritative guidance requiring new asset and liability offsetting disclosures for derivatives, repurchase agreements and security lending transactions to the extent that they are offset in the financial statements or are subject to an enforceable master netting arrangement or similar agreement.  We do not have any repurchase agreements and do not participate in securities lending transactions.  Our derivative instruments are not offset in the financial statements. Accordingly, the adoption of this standard had no impact on the Unaudited Condensed Consolidated Financial Statements other than disclosure.  Additional information can be found in Note 7 of the Unaudited Notes to the Condensed Consolidated Financial Statements.
	Other accounting standards that have been issued by the FASB or other standards-setting bodies are not expected to have a material impact on our Unaudited Condensed Consolidated Financial Statements.
	INCOME TAXES
	The Company computes taxes on income in accordance with the tax rules and regulations of the many taxing authorities where income is earned.  The income tax rates imposed by these taxing authorities may vary substantially.  Taxable income may differ from pretax income for financial accounting purposes.  To the extent that these differences create differences between the tax basis of an asset or liability and our reported amount in the financial statements, an appropriate provision for deferred income taxes is made.
	In our determination of which foreign earnings are permanently reinvested in foreign operations, the Company considers numerous factors, including the financial requirements of the U.S. parent company and those of our foreign subsidiaries, the U.S. funding needs for dividend payments and stock repurchases, and the tax consequences of remitting earnings to the U.S.  From this analysis, current year repatriation decisions are made in an attempt to provide a proper mix of debt and stockholder capital both within the U.S. and for non-U.S. operations.  The Company’s policy is to permanently reinvest our accumulated foreign earnings and will only make a distribution out of current year earnings to meet the cash needs at the parent company.  As such, the Company does not provide for taxes on earnings that are deemed to be permanently reinvested.  Since no distribution to the U.S. of foreign earnings is expected in 2014, the effective tax rate for 2014 includes no tax cost of repatriation. Although the Company does not expect to repatriate foreign earnings back to the U.S. in 2014, dividends on certain earnings within Europe to our European holding company are expected to increase in 2014 as part of a legal reorganization of our non-U.S. subsidiaries.  Due to this legal reorganization, additional tax costs in the third quarter of 2014 were approximately $3.1 million, of which $2.8 million related to the change in our reinvestment assertion within Europe.
	The Company provides a liability for the amount of tax benefits realized from uncertain tax positions.  This liability is provided whenever the Company determines that a tax benefit will not meet a more-likely-than-not threshold for recognition.  See Note 4 of the Unaudited Notes to the Condensed Consolidated Financial Statements for more information.

INVENTORIES

INVENTORIES	9 Months Ended
	Sep. 30, 2014
INVENTORIES	'
INVENTORIES	'
	NOTE 2 - INVENTORIES
	At September 30, 2014 and December 31, 2013, approximately 19% and 20%, respectively, of the total inventories are accounted for by using the LIFO method.  Inventories, by component, consisted of:
		September 30,			December 31,
		2014			2013
	Raw materials	$	115,575		$	114,501
	Work in process	103,262			108,924
	Finished goods	130,055			137,591
	Total	348,892			361,016
	Less LIFO Reserve	(7,940		)	(7,857		)
	Total	$	340,952		$	353,159

GOODWILL_AND_OTHER_INTANGIBLE_

GOODWILL AND OTHER INTANGIBLE ASSETS	9 Months Ended
	Sep. 30, 2014
GOODWILL AND OTHER INTANGIBLE ASSETS	'
GOODWILL AND OTHER INTANGIBLE ASSETS	'
	NOTE 3 – GOODWILL AND OTHER INTANGIBLE ASSETS
	The changes in the carrying amount of goodwill since the year ended December 31, 2013 are as follows by reporting segment:
		Beauty +						Food +			Corporate
		Home			Pharma			Beverage			& Other			Total
	Goodwill	$	181,002		$	159,949		$	17,914		$	1,615		$	360,480
	Accumulated impairment losses	--			--			--			(1,615		)	(1,615		)
	Balance as of December 31, 2013	$	181,002		$	159,949		$	17,914		$	--		$	358,865
	Acquisition	--			--			--			--			--
	Foreign currency exchange effects	(6,574		)	(12,383		)	(633		)	--			(19,590		)
	Goodwill	$	174,428		$	147,566		$	17,281		$	1,615		$	340,890
	Accumulated impairment losses	--			--			--			(1,615		)	(1,615		)
	Balance as of September 30, 2014	$	174,428		$	147,566		$	17,281		$	--		$	339,275
	The table below shows a summary of intangible assets as of September 30, 2014 and December 31, 2013.
				September 30, 2014									December 31, 2013
	Weighted Average			Gross									Gross
	Amortization			Carrying			Accumulated			Net			Carrying			Accumulated			Net
	Period (Years)			Amount			Amortization			Value			Amount			Amortization			Value
	Amortized intangible assets:
	Patents	7		$	18,282		$	(18,067	)	$	215		$	20,165		$	(19,732	)	$	433
	Acquired technology	15		37,260			(5,589		)	31,671			40,546			(4,055		)	36,491
	License agreements and other	5		33,490			(22,825		)	10,665			35,259			(22,232		)	13,027
	Total intangible assets	10		$	89,032		$	(46,481	)	$	42,551		$	95,970		$	(46,019	)	$	49,951
	Aggregate amortization expense for the intangible assets above for the quarters ended September 30, 2014 and 2013 was $1,283 and $1,266, respectively.  Aggregate amortization expense for the intangible assets above for the nine months ended September 30, 2014 and 2013 was $4,050 and $3,748, respectively.
	Future estimated amortization expense for the years ending December 31 is as follows:
	2014	$	1,291	(remaining estimated amortization for 2014)
	2015	4,960
	2016	4,024
	2017	3,338
	2018 and thereafter	28,938
	Future amortization expense may fluctuate depending on changes in foreign currency rates.  The estimates for amortization expense noted above are based upon foreign exchange rates as of September 30, 2014.

INCOME_TAX_UNCERTAINTIES

INCOME TAX UNCERTAINTIES	9 Months Ended
	Sep. 30, 2014
INCOME TAX UNCERTAINTIES	'
INCOME TAX UNCERTAINTIES	'
	NOTE 4 – INCOME TAX UNCERTAINTIES
	The Company had approximately $6.6 and $8.0 million recorded for income tax uncertainties as of September 30, 2014 and December 31, 2013, respectively.  The $1.4 million change in income tax uncertainties is primarily the result of an audit settlement and the lapse in the statute of limitations for certain tax items.  The amount, if recognized, that would impact the effective tax rate is $6.4 and $7.8 million, respectively.  The Company estimates that it is reasonably possible that the liability for uncertain tax positions will decrease by no more than $5  million in the next twelve months from the resolution of various uncertain positions as a result of the completion of tax audits, litigation and the expiration of the statute of limitations in various jurisdictions.

RETIREMENT_AND_DEFERRED_COMPEN

RETIREMENT AND DEFERRED COMPENSATION PLANS	9 Months Ended
	Sep. 30, 2014
RETIREMENT AND DEFERRED COMPENSATION PLANS	'
RETIREMENT AND DEFERRED COMPENSATION PLANS	'
	NOTE 5 – RETIREMENT AND DEFERRED COMPENSATION PLANS
	Components of Net Periodic Benefit Cost:
		Domestic Plans						Foreign Plans
	Three months ended September 30,	2014			2013			2014			2013
	Service cost	$	2,011		$	2,135		$	1,043		$	974
	Interest cost	1,482			1,248			676			668
	Expected return on plan assets	(1,647		)	(1,443		)	(494		)	(454		)
	Amortization of net loss	718			1,276			303			353
	Amortization of prior service cost	--			--			78			93
	Net periodic benefit cost	$	2,564		$	3,216		$	1,606		$	1,634
		Domestic Plans						Foreign Plans
	Nine months ended September 30,	2014			2013			2014			2013
	Service cost	$	6,032		$	6,405		$	3,203		$	2,902
	Interest cost	4,446			3,744			2,074			1,991
	Expected return on plan assets	(4,939		)	(4,331		)	(1,514		)	(1,353		)
	Amortization of net loss	2,152			3,827			929			1,053
	Amortization of prior service cost	--			2			239			278
	Net periodic benefit cost	$	7,691		$	9,647		$	4,931		$	4,871
	EMPLOYER CONTRIBUTIONS
	Although the Company has no minimum funding requirement, the Company contributed $10.0 million to our U.S. plan during the third quarter and the first nine months of 2014 and does not expect to make any contribution to the U.S. plan in the last quarter of 2014.  The Company expects to contribute approximately $5.6 million to our foreign defined benefit plans in 2014 and, as of September 30, 2014, we have contributed approximately $2.0 million.

ACCUMULATED_OTHER_COMPREHENSIV

ACCUMULATED OTHER COMPREHENSIVE INCOME	9 Months Ended
	Sep. 30, 2014
ACCUMULATED OTHER COMPREHENSIVE INCOME	'
ACCUMULATED OTHER COMPREHENSIVE INCOME	'
	NOTE 6 – ACCUMULATED OTHER COMPREHENSIVE INCOME
	Changes in Accumulated Other Comprehensive Income by Component:
			Foreign			Defined Benefit			Other			Total
			Currency			Pension Plans
	Balance – December 31, 2012		$	120,097		$	(59,248	)	$	(166	)	$	60,683
	Other comprehensive income before reclassifications		16,275			--			--			16,275
	Amounts reclassified from accumulated other comprehensive income		--			3,294			39			3,333
	Net current-period other comprehensive income		16,275			3,294			39			19,608
	Balance – September 30, 2013		$	136,372		$	(55,954	)	$	(127	)	$	80,291
	Balance – December 31, 2013		$	149,965		$	(40,093	)	$	(121	)	$	109,751
	Other comprehensive loss before reclassifications		(123,014		)	--			--			(123,014		)
	Amounts reclassified from accumulated other comprehensive income		(340		)	2,144			18			1,822
	Net current-period other comprehensive (loss) income		(123,354		)	2,144			18			(121,192		)
	Balance – September 30, 2014		$	26,611		$	(37,949	)	$	(103	)	$	(11,441	)
	Reclassifications Out of Accumulated Other Comprehensive Income:
	Details about Accumulated Other		Amount Reclassified from Accumulated						Affected Line in the Statement
	Comprehensive Income Components		Other Comprehensive Income						Where Net Income is Presented
	Three months ended September 30,		2014			2013
	Defined Benefit Pension Plans
	Amortization of net loss		$	1,021		$	1,629		(a)
	Amortization of prior service cost		78			93			(a)
	Total before tax		1,099			1,722
			(390		)	(622		)	Tax benefit
	Net of tax		$	709		$	1,100
	Other
	Changes in treasury locks		9			14			Interest Expense
	Total before tax		9			14
			(3		)	(5		)	Tax benefit
	Net of tax		$	6		$	9
	Total reclassifications for the period		$	715		$	1,109
		(a)		These accumulated other comprehensive income components are included in the computation of net periodic benefit costs, net of tax (see Note 5 – Retirement and Deferred Compensation Plans for additional details).
	Details about Accumulated Other		Amount Reclassified from Accumulated						Affected Line in the Statement
	Comprehensive Income Components		Other Comprehensive Income						Where Net Income is Presented
	Nine months ended September 30,		2014			2013
	Defined Benefit Pension Plans
	Amortization of net loss		$	3,081		$	4,880		(b)
	Amortization of prior service cost		239			280			(b)
	Total before tax		3,320			5,160
			(1,176		)	(1,866		)	Tax benefit
	Net of tax		$	2,144		$	3,294
	Foreign Currency
	Foreign currency gain		(340		)	--			Miscellaneous, net
	Total before tax		(340		)	--
			--			--			Tax benefit
	Net of tax		$	(340	)	$	--
	Other
	Changes in treasury locks		28			60			Interest Expense
	Total before tax		28			60
			(10		)	(21		)	Tax benefit
	Net of tax		$	18		$	39
	Total reclassifications for the period		$	1,822		$	3,333
		(b)		These accumulated other comprehensive income components are included in the computation of net periodic benefit costs, net of tax (see Note 5 – Retirement and Deferred Compensation Plans for additional details).

DERIVATIVE_INSTRUMENTS_AND_HED

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	9 Months Ended
	Sep. 30, 2014
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	'
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	'
	NOTE 7 – DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
	The Company maintains a foreign exchange risk management policy designed to establish a framework to protect the value of the Company’s non-functional denominated transactions from adverse changes in exchange rates.  Sales of the Company’s products can be denominated in a currency different from the currency in which the related costs to produce the product are denominated.  Changes in exchange rates on such inter-country sales or intercompany loans can impact the Company’s results of operations.  The Company’s policy is not to engage in speculative foreign currency hedging activities, but to minimize our net foreign currency transaction exposure, defined as firm commitments and transactions recorded and denominated in currencies other than the functional currency.  The Company may use foreign currency forward exchange contracts, options and cross currency swaps to economically hedge these risks.
	The Company maintains an interest rate risk management strategy to minimize significant, unanticipated earnings fluctuations that may arise from volatility in interest rates.
	For derivative instruments designated as hedges, the Company formally documents the nature and relationships between the hedging instruments and the hedged items, as well as the risk management objectives, strategies for undertaking the various hedge transactions, and the method of assessing hedge effectiveness.  Additionally, in order to designate any derivative instrument as a hedge of an anticipated transaction, the significant characteristics and expected terms of any anticipated transaction must be specifically identified, and it must be probable that the anticipated transaction will occur.
	HEDGE OF NET INVESTMENTS IN FOREIGN OPERATIONS
	A significant number of the Company’s operations are located outside of the United States.  Because of this, movements in exchange rates may have a significant impact on the translation of the financial condition and results of operations of the Company’s foreign subsidiaries.  A strengthening U.S. dollar relative to foreign currencies has a dilutive translation effect on the Company’s financial condition and results of operations.  Conversely, a weakening U.S. dollar has an additive effect.  The Company in some cases maintains debt in these subsidiaries to offset the net asset exposure.  The Company does not otherwise actively manage this risk using derivative financial instruments.  In the event the Company plans on a full or partial liquidation of any of our foreign subsidiaries where the Company’s net investment is likely to be monetized, the Company will consider hedging the currency exposure associated with such a transaction.
	OTHER
	As of September 30, 2014, the Company has recorded the fair value of foreign currency forward exchange contracts of $0.8 million in prepaid and other, $0.1 million in miscellaneous other assets, $3.0 million in accounts payable and accrued liabilities, and $0.3 million in deferred and other non-current liabilities in the balance sheet.  All forward exchange contracts outstanding as of September 30, 2014 had an aggregate contract amount of $155 million.
	Fair Value of Derivative Instruments in the Condensed Consolidated Balance Sheets as of September 30, 2014
	and December 31, 2013
	Derivative Contracts Not Designated	Balance Sheet		September			December
	as Hedging Instruments	Location		30, 2014			31, 2013
	Derivative Assets
	Foreign Exchange Contracts	Prepaid and other		$	801		$	3,003
	Foreign Exchange Contracts	Miscellaneous Other Assets		62			985
				$	863		$	3,988
	Derivative Liabilities
	Foreign Exchange Contracts	Accounts payable and accrued liabilities		$	3,044		$	522
	Foreign Exchange Contracts	Deferred and other non-current liabilities		345			110
				$	3,389		$	632
	The Effect of Derivative Instruments on the Condensed Consolidated Statements of Income
	for the Quarters Ended September 30, 2014 and September 30, 2013
	Derivatives Not Designated as	Location of (Loss) or Gain Recognized in		Amount of (Loss) or Gain
	Hedging Instruments	Income on Derivative		Recognized in Income on
				Derivative
				2014			2013
	Foreign Exchange Contracts	Other Income (Expense) Miscellaneous, net		$	(1,965	)	$	2,894
				$	(1,965	)	$	2,894
	The Effect of Derivative Instruments on the Condensed Consolidated Statements of Income
	for the Nine Months Ended September 30, 2014 and September 30, 2013
	Derivatives Not Designated as	Location of (Loss) or Gain Recognized in		Amount of (Loss) or Gain
	Hedging Instruments	Income on Derivative		Recognized in Income on
				Derivative
				2014			2013
	Foreign Exchange Contracts	Other Income (Expense) Miscellaneous, net		$	(3,459	)	$	2,851
				$	(3,459	)	$	2,851
							Net Amounts		Gross Amounts not Offset in the
					Gross Amounts		Presented in		Statement of Financial Position
		Gross			Offset in the		the Statement of		Financial	Cash Collateral	Net
		Amount			Financial Position		Financial Position		Instruments	Received	Amount
	Description
	September 30, 2014
	Derivative Assets	$	863		--		$	863	--	--	$	863
	Total Assets	$	863		--		$	863	--	--	$	863
	Derivative Liabilities	$	3,389		--		$	3,389	--	--	$	3,389
	Total Liabilities	$	3,389		--		$	3,389	--	--	$	3,389
	December 31, 2013
	Derivative Assets	$	3,988		--		$	3,988	--	--	$	3,988
	Total Assets	$	3,988		--		$	3,988	--	--	$	3,988
	Derivative Liabilities	$	632		--		$	632	--	--	$	632
	Total Liabilities	$	632		--		$	632	--	--	$	632

FAIR_VALUE

FAIR VALUE	9 Months Ended
	Sep. 30, 2014
FAIR VALUE	'
FAIR VALUE	'
	NOTE 8 – FAIR VALUE
	Authoritative guidelines require the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities.  Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment.  The three levels are defined as follows:
		·		Level 1:Unadjusted quoted prices in active markets for identical assets and liabilities.
		·		Level 2:Observable inputs other than those included in Level 1.  For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.
		·		Level 3:Unobservable inputs reflecting management’s own assumptions about the inputs used in pricing the asset or liability.
	As of September 30, 2014, the fair values of our financial assets and liabilities were categorized as follows:
			Total		Level 1		Level 2		Level 3
	Assets
	Forward exchange contracts (a)		$	863	$	--	$	863	$	--
	Total assets at fair value		$	863	$	--	$	863	$	--
	Liabilities
	Forward exchange contracts (a)		$	3,389	$	--	$	3,389	$	--
	Total liabilities at fair value		$	3,389	$	--	$	3,389	$	--
	As of December 31, 2013, the fair values of our financial assets and liabilities were categorized as follows:
			Total		Level 1		Level 2		Level 3
	Assets
	Forward exchange contracts (a)		$	3,988	$	--	$	3,988	$	--
	Total assets at fair value		$	3,988	$	--	$	3,988	$	--
	Liabilities
	Forward exchange contracts (a)		$	632	$	--	$	632	$	--
	Total liabilities at fair value		$	632	$	--	$	632	$	--
		(a)		Market approach valuation technique based on observable market transactions of spot and forward rates
	The carrying amounts of the Company’s other current financial instruments such as cash and equivalents, notes payable and current maturities of long-term obligations approximate fair value due to the short-term maturity of the instrument.  The Company considers our long-term obligations a Level 2 liability and utilizes the market approach valuation technique based on interest rates that are currently available to the Company for issuance of debt with similar terms and maturities.  The estimated fair value of the Company’s long-term obligations was $370 million as of September 30, 2014 and $363 million as of December 31, 2013.

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2014
COMMITMENTS AND CONTINGENCIES	'
COMMITMENTS AND CONTINGENCIES	'
	NOTE 9 – COMMITMENTS AND CONTINGENCIES
	The Company, in the normal course of business, is subject to a number of lawsuits and claims both actual and potential in nature.  While management believes the resolution of these claims and lawsuits will not have a material adverse effect on the Company’s financial position or results of operations or cash flows, claims and legal proceedings are subject to inherent uncertainties, and unfavorable outcomes could occur that could include amounts in excess of any accruals which management has established.  Were such unfavorable final outcomes to occur, it is possible that they could have a material adverse effect on our financial position, results of operations and cash flows.

STOCK_REPURCHASE_PROGRAM

STOCK REPURCHASE PROGRAM	9 Months Ended
	Sep. 30, 2014
STOCK REPURCHASE PROGRAM	'
STOCK REPURCHASE PROGRAM	'
	NOTE 10 – STOCK REPURCHASE PROGRAM
	During the three and nine months ended September 30, 2014, the Company repurchased approximately 600 thousand and 1.4 million shares for approximately $37.6 million and $90.5 million, respectively.  As of September 30, 2014, the Company has a remaining authorization to repurchase 2.6 million additional shares.  The timing of and total amount expended for the share repurchases depends upon market conditions.  On October 30, 2014, the Company announced a new share repurchase authorization of up to $350 million of common stock.  This new authorization replaces previous authorizations.  AptarGroup may repurchase shares through the open market, privately negotiated transactions or other programs, subject to market conditions.

STOCKBASED_COMPENSATION

STOCK-BASED COMPENSATION	9 Months Ended
	Sep. 30, 2014
STOCK-BASED COMPENSATION	'
STOCK-BASED COMPENSATION	'
	NOTE 11 – STOCK-BASED COMPENSATION
	The Company issues stock options and restricted stock units to employees under Stock Awards Plans approved by stockholders.  Stock options are issued to non-employee directors under Director Stock Option Plans approved by stockholders. Options are awarded with the exercise price equal to the closing market price on the date of grant and generally become exercisable over three years and expire 10 years after grant.  Restricted stock units generally vest over three years.
	Compensation expense recorded attributable to stock options for the first nine months of 2014 was approximately $15.0 million ($9.8 million after tax).  The income tax benefit related to this compensation expense was approximately $5.2 million.  Approximately $13.4 million of the compensation expense was recorded in selling, research & development and administrative expenses and the balance was recorded in cost of sales.  Compensation expense recorded attributable to stock options for the first nine months of 2013 was approximately $11.5 million ($7.7 million after tax).  The income tax benefit related to this compensation expense was approximately $3.8 million.  Approximately $10.2 million of the compensation expense was recorded in selling, research & development and administrative expenses and the balance was recorded in cost of sales.
	The Company uses historical data to estimate expected life and volatility of stock options.  The weighted-average fair value of stock options granted under the Stock Awards Plans was $14.82 and $10.16 per share during the first nine months of 2014 and 2013, respectively.  These values were estimated on the respective dates of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:
	Stock Awards Plans:
	Nine months ended September 30,	2014		2013
	Dividend Yield	1.7	%	1.8	%
	Expected Stock Price Volatility	22.1	%	22.7	%
	Risk-free Interest Rate	2.3	%	1.3	%
	Expected Life of Option (years)	6.9		6.9
	The fair value of stock options granted under the Director Stock Option Plan was $14.07 and $10.89 per share during the first nine months of 2014 and 2013, respectively.  These values were estimated on the respective dates of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:
	Director Stock Option Plans:
	Nine months ended September 30,	2014		2013
	Dividend Yield	1.8	%	1.9	%
	Expected Stock Price Volatility	22.2	%	23.0	%
	Risk-free Interest Rate	2.2	%	1.3	%
	Expected Life of Option (years)	6.9		6.9
	A summary of option activity under the Company’s stock option plans during the nine months ended September 30, 2014 is presented below:
		Stock Awards Plans					Director Stock Option Plans
					Weighted Average					Weighted Average
		Shares			Exercise Price		Shares			Exercise Price
	Outstanding, January 1, 2014	7,815,932			$	41.26	313,834			$	48.85
	Granted	1,379,850			67.93		95,000			66.59
	Exercised	(665,671		)	32.23		(40,166		)	47.96
	Forfeited or expired	(31,417		)	49.86		--			--
	Outstanding at September 30, 2014	8,498,694			$	46.27	368,668			$	53.52
	Exercisable at September 30, 2014	5,832,623			$	39.94	188,159			$	45.98
	Weighted-Average Remaining Contractual Term (Years):
	Outstanding at September 30, 2014	6.1					7.5
	Exercisable at September 30, 2014	5					6.1
	Aggregate Intrinsic Value:
	Outstanding at September 30, 2014	$	132,612				$	3,208
	Exercisable at September 30, 2014	$	121,124				$	2,769
	Intrinsic Value of Options Exercised During the Nine Months Ended:
	September 30, 2014	$	22,386				$	741
	September 30, 2013	$	33,123				$	732
	The fair value of options vested during the nine months ended September 30, 2014 and 2013 was $14.1 million and $12.9 million, respectively.  Cash received from option exercises was approximately $24.6 million and the actual tax benefit realized for the tax deduction from option exercises was approximately $7.0 million in the nine months ended September 30, 2014.  As of September 30, 2014, the remaining valuation of stock option awards to be expensed in future periods was $16.1 million and the related weighted-average period over which it is expected to be recognized is 1.5 years.
	The fair value of restricted stock unit grants is the closing market price of the underlying shares on the grant date.  A summary of restricted stock unit activity during the nine months ended September 30, 2014 is presented below:
				Weighted-Average
		Shares		Grant-Date Fair Value
	Nonvested at January 1, 2014	25,681		$	53.49
	Granted	47,671		67.08
	Vested	(11,602	)	52.96
	Nonvested at September 30, 2014	61,750		$	64.09
	Compensation expense recorded attributable to restricted stock unit grants for the first nine months of 2014 and 2013 was approximately $1.4 million and $574 thousand, respectively.  The fair value of units vested during the nine months ended September 30, 2014 and 2013 was $614 thousand and $571 thousand, respectively.  The intrinsic value of units vested during the nine months ended September 30, 2014 and 2013 was $761 thousand and $661 thousand, respectively.  As of September 30, 2014 there was $2.3 million of total unrecognized compensation expense relating to restricted stock unit awards which is expected to be recognized over a weighted-average period of 1.6 years.
	During the first quarter of 2014, the Company approved a new long-term incentive program for certain employees.  The program is based on the cumulative total stockholder return of our common stock during a three year performance period.  Total expense related to this program is expected to be approximately $1.2 million over the performance period, of which $480 thousand was recognized in the first nine months of 2014.

EARNINGS_PER_SHARE

EARNINGS PER SHARE	9 Months Ended
	Sep. 30, 2014
EARNINGS PER SHARE	'
EARNINGS PER SHARE	'
	NOTE 12 – EARNINGS PER SHARE
	AptarGroup’s authorized common stock consists of 199 million shares, having a par value of $.01 each.  Information related to the calculation of earnings per share is as follows:
		Three months ended
		September 30, 2014				September 30, 2013
		Diluted		Basic		Diluted		Basic
	Consolidated operations
	Income available to common stockholders	$	48,595	$	48,595	$	45,264	$	45,264
	Average equivalent shares
	Shares of common stock	64,886		64,886		66,092		66,092
	Effect of dilutive stock based compensation
	Stock options	1,953		--		1,887		--
	Restricted stock units	6		--		7		--
	Total average equivalent shares	66,845		64,886		67,986		66,092
	Net income per share	$	0.73	$	0.75	$	0.67	$	0.68
		Nine months ended
		September 30, 2014				September 30, 2013
		Diluted		Basic		Diluted		Basic
	Consolidated operations
	Income available to common stockholders	$	150,060	$	150,060	$	135,095	$	135,095
	Average equivalent shares
	Shares of common stock	65,225		65,225		66,222		66,222
	Effect of dilutive stock based compensation
	Stock options	2,505		--		2,041		--
	Restricted stock units	31		--		10		--
	Total average equivalent shares	67,761		65,225		68,273		66,222
	Net income per share	$	2.21	$	2.30	$	1.98	$	2.04

SEGMENT_INFORMATION

SEGMENT INFORMATION	9 Months Ended
	Sep. 30, 2014
SEGMENT INFORMATION	'
SEGMENT INFORMATION	'
	NOTE 13 – SEGMENT INFORMATION
	The Company operates in the packaging components industry, which includes the development, manufacture and sale of consumer product dispensing solutions.  The Company is organized into three reporting segments.  Operations that sell dispensing systems primarily to the personal care, beauty and home care markets form the Beauty + Home segment.  Operations that sell dispensing systems primarily to the prescription drug, consumer health care and injectables markets form the Pharma segment.  Operations that sell dispensing systems primarily to the food and beverage markets form the Food + Beverage segment.
	The accounting policies of the segments are the same as those described in Note 1, Summary of Significant Accounting Policies in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.  Segment income is defined as earnings before net interest expense, certain corporate expenses, restructuring initiatives and related depreciation and income taxes.
	Financial information regarding the Company’s reportable segments is shown below:
			Three Months Ended September 30,						Nine Months Ended September 30,
			2014			2013			2014			2013
	Total Revenue:
	Beauty + Home		$	384,604		$	379,250		$	1,174,359		$	1,125,261
	Pharma		179,191			172,360			569,230			524,248
	Food + Beverage		94,118			75,531			274,936			244,434
	Total Revenue		657,913			627,141			2,018,525			1,893,943
	Less: Intersegment Sales:
	Beauty + Home		$	5,699		$	3,199		$	18,992		$	10,754
	Pharma		--			90			--			178
	Food + Beverage		272			208			909			293
	Total Intersegment Sales		$	5,971		$	3,497		$	19,901		$	11,225
	Net Sales:
	Beauty + Home		$	378,905		$	376,051		$	1,155,367		$	1,114,507
	Pharma		179,191			172,270			569,230			524,070
	Food + Beverage		93,846			75,323			274,027			244,141
	Net Sales		$	651,942		$	623,644		$	1,998,624		$	1,882,718
	Segment Income:
	Beauty + Home		$	25,399		$	30,943		$	80,378		$	85,697
	Pharma		49,314			44,737			154,589			141,154
	Food + Beverage		11,713			7,688			33,209			28,102
	Restructuring Initiatives and
	Related Depreciation (1)		--			(2,664		)	--			(10,257		)
	Corporate & Other		(8,364		)	(8,113		)	(28,664		)	(27,605		)
	Income before interest and taxes		$	78,062		$	72,591		$	239,512		$	217,091
	Interest expense, net		(3,946		)	(4,265		)	(12,010		)	(13,093		)
	Income before income taxes		$	74,116		$	68,326		$	227,502		$	203,998
		-1		Restructuring Initiatives and Related Depreciation includes the following income/(expense) items for the three and nine months ended September 30, 2014:
			Three Months Ended September 30,						Nine Months Ended September 30,
			2014			2013			2014			2013
	European Restructuring Plan
	Depreciation		$	--		$	484		$	--		$	1,499
	Employee Severance and Other Costs		--			2,180			--			8,802
	Prior Year Initiatives		--			--			--			(44		)
	Total Restructuring Initiatives and Related Depreciation Expense		$	--		$	2,664		$	--		$	10,257
	Restructuring Initiatives and Related Depreciation Expense by Segment
	Beauty + Home		$	--		$	2,664		$	--		$	10,280
	Pharma		--			--			--			--
	Food + Beverage		--			--			--			(23		)
	Total Restructuring Initiatives and Related Depreciation Expense		$	--		$	2,664		$	--		$	10,257

NONRECURRING_EVENTS

NONRECURRING EVENTS	9 Months Ended
	Sep. 30, 2014
NONRECURRING EVENTS	'
NONRECURRING EVENTS	'
	NOTE 14 – NONRECURRING EVENTS
	A fire caused damages to the roof and production area of an AptarGroup subsidiary, Graphocolor do Brasil Embalagens Ltda, on September 1, 2014.  Graphocolor is located in Jundiai, Brazil.  There were no reported injuries.  Graphocolor is primarily an internal supplier to AptarGroup of anodized aluminum components for certain dispensing systems sold to the regional beauty and personal care markets.  Until repairs to the Jundiai facility are completed, the company is using sourcing alternatives, including local sourcing and its affiliated anodizing facilities in France and the U.S. that currently import some components to the region.  AptarGroup is insured for the damages caused by the fire, including business interruption insurance, and it does not expect this incident to have a material impact on its financial results.  Costs, including the write-off of damaged fixed assets and inventory along with labor and other direct costs related to fire, of $3.7 million were incurred during the quarter.  These costs have been reported within the Condensed Consolidated Statements of Income and have been offset by the expected insurance proceeds within the same financial statement line items as the losses.
	As we are still in the investigation phase, we have only established an insurance receivable for known losses for which we feel insurance reimbursement is probable.  In many cases, our insurance coverage exceeds the amount of these covered losses, but no gain contingencies have been recognized as our ability to realize those gains remains uncertain for financial reporting purposes.

ACQUISITIONS

ACQUISITIONS	9 Months Ended
	Sep. 30, 2014
ACQUISITIONS	'
ACQUISITIONS	'
	NOTE 15 - ACQUISITIONS
	In December 2013, AptarGroup acquired a 20% non-controlling investment in Bapco Closures Holding Limited (Bapco) for approximately $5.2 million.  In addition to this equity stake, the Company secured an exclusive global license related to innovative closures sealing technology that provides package integrity and tamper evidence.  This investment is being accounted for under the equity method of accounting from the date of acquisition and, since it does not have a material impact on the results of operations in 2014 or 2013, pro forma information is not presented.

RESTRUCTURING_INITIATIVE

RESTRUCTURING INITIATIVE	9 Months Ended
	Sep. 30, 2014
RESTRUCTURING INITIATIVE	'
RESTRUCTURING INITIATIVE	'
	NOTE 16 – RESTRUCTURING INITIATIVE
	In November 2012, the Company announced a plan to optimize certain capacity in Europe.  Due to increased production efficiencies and to better position the Company for future growth in Europe, AptarGroup transferred and consolidated production capacity involving twelve facilities.  Two facilities have closed impacting approximately 170 employees.  The locations involved in the plan are facilities serving the beauty, personal care, food, beverage, and consumer health care markets.  As of December 31, 2013, the plan was substantially complete.  The cumulative expense incurred was $19.5 million.  As of September 30, 2014 we have recorded the following activity associated with our European restructuring plan:
		Beginning		Net Charges for								Ending
		Reserve at		the Nine Months								Reserve at
		12/31/13		Ended 9/30/14		Cash Paid			FX Impact			9/30/14
	Employee severance	$	2,521	$	--	$	(1,933	)	$	(158	)	$	430
	Other costs	1,735		--		(1,568		)	(82		)	85
	Totals	$	4,256	$	--	$	(3,501	)	$	(240	)	$	515

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
BASIS OF PRESENTATION	'
	BASIS OF PRESENTATION
	The accompanying Unaudited Condensed Consolidated Financial Statements include the accounts of AptarGroup, Inc. and our subsidiaries.  The terms “AptarGroup” or “Company” as used herein refer to AptarGroup, Inc. and our subsidiaries.  All significant intercompany accounts and transactions have been eliminated.
	In the opinion of management, the Unaudited Condensed Consolidated Financial Statements include all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of consolidated financial position, results of operations, comprehensive income, changes in equity and cash flows for the interim periods presented.  The accompanying Unaudited Condensed Consolidated Financial Statements have been prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”).  Certain information and footnote disclosure normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures made are adequate to make the information presented not misleading.  Also, certain financial position data included herein was derived from the Audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013 but does not include all disclosures required by GAAP.  Accordingly, these Unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with the Audited Consolidated Financial Statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.  The results of operations of any interim period are not necessarily indicative of the results that may be expected for the year.
ADOPTION OF RECENT ACCOUNTING PRONOUNCEMENTS	'
	ADOPTION OF RECENT ACCOUNTING PRONOUNCEMENTS
	Changes to GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of accounting standards updates to the FASB’s Accounting Standards Codification.
	In July 2013, the FASB issued authoritative guidance on the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists.  This standard requires an entity to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward.  The guidance is effective for the Company’s fiscal years beginning after December 15, 2013.  This standard did not impact our current year financial statements as this was already the Company’s existing reporting treatment.
	In March 2013, the FASB issued authoritative guidance which permits an entity to release cumulative translation adjustments into net income when a reporting entity (parent) ceases to have a controlling financial interest in a subsidiary or group of assets that is a business within a foreign entity.  Accordingly, the cumulative translation adjustment should be released into net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided, or if a controlling financial interest is no longer held. The guidance is effective for the Company’s fiscal years beginning after December 15, 2013.  This standard has only a minimal impact on our current year financial statements.
	In February 2013, the FASB issued authoritative guidance that amends the presentation of accumulated other comprehensive income and clarifies how to report the effect of significant reclassifications out of accumulated other comprehensive income.  The guidance requires footnote disclosures regarding the changes in accumulated other comprehensive income by component and the line items affected in the statements of earnings.  The adoption of this standard had no impact on the Unaudited Condensed Consolidated Financial Statements other than disclosure.  Additional information can be found in Note 6 of the Unaudited Notes to the Condensed Consolidated Financial Statements.
	In January 2013, the FASB issued authoritative guidance requiring new asset and liability offsetting disclosures for derivatives, repurchase agreements and security lending transactions to the extent that they are offset in the financial statements or are subject to an enforceable master netting arrangement or similar agreement.  We do not have any repurchase agreements and do not participate in securities lending transactions.  Our derivative instruments are not offset in the financial statements. Accordingly, the adoption of this standard had no impact on the Unaudited Condensed Consolidated Financial Statements other than disclosure.  Additional information can be found in Note 7 of the Unaudited Notes to the Condensed Consolidated Financial Statements.
	Other accounting standards that have been issued by the FASB or other standards-setting bodies are not expected to have a material impact on our Unaudited Condensed Consolidated Financial Statements.
INCOME TAXES	'
	INCOME TAXES
	The Company computes taxes on income in accordance with the tax rules and regulations of the many taxing authorities where income is earned.  The income tax rates imposed by these taxing authorities may vary substantially.  Taxable income may differ from pretax income for financial accounting purposes.  To the extent that these differences create differences between the tax basis of an asset or liability and our reported amount in the financial statements, an appropriate provision for deferred income taxes is made.
	In our determination of which foreign earnings are permanently reinvested in foreign operations, the Company considers numerous factors, including the financial requirements of the U.S. parent company and those of our foreign subsidiaries, the U.S. funding needs for dividend payments and stock repurchases, and the tax consequences of remitting earnings to the U.S.  From this analysis, current year repatriation decisions are made in an attempt to provide a proper mix of debt and stockholder capital both within the U.S. and for non-U.S. operations.  The Company’s policy is to permanently reinvest our accumulated foreign earnings and will only make a distribution out of current year earnings to meet the cash needs at the parent company.  As such, the Company does not provide for taxes on earnings that are deemed to be permanently reinvested.  Since no distribution to the U.S. of foreign earnings is expected in 2014, the effective tax rate for 2014 includes no tax cost of repatriation. Although the Company does not expect to repatriate foreign earnings back to the U.S. in 2014, dividends on certain earnings within Europe to our European holding company are expected to increase in 2014 as part of a legal reorganization of our non-U.S. subsidiaries.  Due to this legal reorganization, additional tax costs in the third quarter of 2014 were approximately $3.1 million, of which $2.8 million related to the change in our reinvestment assertion within Europe.
	The Company provides a liability for the amount of tax benefits realized from uncertain tax positions.  This liability is provided whenever the Company determines that a tax benefit will not meet a more-likely-than-not threshold for recognition.  See Note 4 of the Unaudited Notes to the Condensed Consolidated Financial Statements for more information.

INVENTORIES_Tables

INVENTORIES (Tables)	9 Months Ended
	Sep. 30, 2014
INVENTORIES	'
Schedule of inventories, by component	'
		September 30,			December 31,
		2014			2013
	Raw materials	$	115,575		$	114,501
	Work in process	103,262			108,924
	Finished goods	130,055			137,591
	Total	348,892			361,016
	Less LIFO Reserve	(7,940		)	(7,857		)
	Total	$	340,952		$	353,159

GOODWILL_AND_OTHER_INTANGIBLE_1

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	9 Months Ended
	Sep. 30, 2014
GOODWILL AND OTHER INTANGIBLE ASSETS	'
Schedule of changes in the carrying amount of goodwill	'
		Beauty +						Food +			Corporate
		Home			Pharma			Beverage			& Other			Total
	Goodwill	$	181,002		$	159,949		$	17,914		$	1,615		$	360,480
	Accumulated impairment losses	--			--			--			(1,615		)	(1,615		)
	Balance as of December 31, 2013	$	181,002		$	159,949		$	17,914		$	--		$	358,865
	Acquisition	--			--			--			--			--
	Foreign currency exchange effects	(6,574		)	(12,383		)	(633		)	--			(19,590		)
	Goodwill	$	174,428		$	147,566		$	17,281		$	1,615		$	340,890
	Accumulated impairment losses	--			--			--			(1,615		)	(1,615		)
	Balance as of September 30, 2014	$	174,428		$	147,566		$	17,281		$	--		$	339,275
Summary of amortized intangible assets	'
				September 30, 2014									December 31, 2013
	Weighted Average			Gross									Gross
	Amortization			Carrying			Accumulated			Net			Carrying			Accumulated			Net
	Period (Years)			Amount			Amortization			Value			Amount			Amortization			Value
	Amortized intangible assets:
	Patents	7		$	18,282		$	(18,067	)	$	215		$	20,165		$	(19,732	)	$	433
	Acquired technology	15		37,260			(5,589		)	31,671			40,546			(4,055		)	36,491
	License agreements and other	5		33,490			(22,825		)	10,665			35,259			(22,232		)	13,027
	Total intangible assets	10		$	89,032		$	(46,481	)	$	42,551		$	95,970		$	(46,019	)	$	49,951
Schedule of future estimated amortization expense	'
	Future estimated amortization expense for the years ending December 31 is as follows:
	2014	$	1,291	(remaining estimated amortization for 2014)
	2015	4,960
	2016	4,024
	2017	3,338
	2018 and thereafter	28,938

RETIREMENT_AND_DEFERRED_COMPEN1

RETIREMENT AND DEFERRED COMPENSATION PLANS (Tables)	9 Months Ended
	Sep. 30, 2014
RETIREMENT AND DEFERRED COMPENSATION PLANS	'
Components of Net Periodic Benefit Cost	'
		Domestic Plans						Foreign Plans
	Three months ended September 30,	2014			2013			2014			2013
	Service cost	$	2,011		$	2,135		$	1,043		$	974
	Interest cost	1,482			1,248			676			668
	Expected return on plan assets	(1,647		)	(1,443		)	(494		)	(454		)
	Amortization of net loss	718			1,276			303			353
	Amortization of prior service cost	--			--			78			93
	Net periodic benefit cost	$	2,564		$	3,216		$	1,606		$	1,634
		Domestic Plans						Foreign Plans
	Nine months ended September 30,	2014			2013			2014			2013
	Service cost	$	6,032		$	6,405		$	3,203		$	2,902
	Interest cost	4,446			3,744			2,074			1,991
	Expected return on plan assets	(4,939		)	(4,331		)	(1,514		)	(1,353		)
	Amortization of net loss	2,152			3,827			929			1,053
	Amortization of prior service cost	--			2			239			278
	Net periodic benefit cost	$	7,691		$	9,647		$	4,931		$	4,871

ACCUMULATED_OTHER_COMPREHENSIV1

ACCUMULATED OTHER COMPREHENSIVE INCOME (Tables)	9 Months Ended
	Sep. 30, 2014
ACCUMULATED OTHER COMPREHENSIVE INCOME	'
Changes in Accumulated Other Comprehensive Income by Component	'
			Foreign			Defined Benefit			Other			Total
			Currency			Pension Plans
	Balance – December 31, 2012		$	120,097		$	(59,248	)	$	(166	)	$	60,683
	Other comprehensive income before reclassifications		16,275			--			--			16,275
	Amounts reclassified from accumulated other comprehensive income		--			3,294			39			3,333
	Net current-period other comprehensive income		16,275			3,294			39			19,608
	Balance – September 30, 2013		$	136,372		$	(55,954	)	$	(127	)	$	80,291
	Balance – December 31, 2013		$	149,965		$	(40,093	)	$	(121	)	$	109,751
	Other comprehensive loss before reclassifications		(123,014		)	--			--			(123,014		)
	Amounts reclassified from accumulated other comprehensive income		(340		)	2,144			18			1,822
	Net current-period other comprehensive (loss) income		(123,354		)	2,144			18			(121,192		)
	Balance – September 30, 2014		$	26,611		$	(37,949	)	$	(103	)	$	(11,441	)
Reclassifications Out of Accumulated Other Comprehensive Income	'
	Details about Accumulated Other		Amount Reclassified from Accumulated						Affected Line in the Statement
	Comprehensive Income Components		Other Comprehensive Income						Where Net Income is Presented
	Three months ended September 30,		2014			2013
	Defined Benefit Pension Plans
	Amortization of net loss		$	1,021		$	1,629		(a)
	Amortization of prior service cost		78			93			(a)
	Total before tax		1,099			1,722
			(390		)	(622		)	Tax benefit
	Net of tax		$	709		$	1,100
	Other
	Changes in treasury locks		9			14			Interest Expense
	Total before tax		9			14
			(3		)	(5		)	Tax benefit
	Net of tax		$	6		$	9
	Total reclassifications for the period		$	715		$	1,109
		(a)		These accumulated other comprehensive income components are included in the computation of net periodic benefit costs, net of tax (see Note 5 – Retirement and Deferred Compensation Plans for additional details).
	Details about Accumulated Other		Amount Reclassified from Accumulated						Affected Line in the Statement
	Comprehensive Income Components		Other Comprehensive Income						Where Net Income is Presented
	Nine months ended September 30,		2014			2013
	Defined Benefit Pension Plans
	Amortization of net loss		$	3,081		$	4,880		(b)
	Amortization of prior service cost		239			280			(b)
	Total before tax		3,320			5,160
			(1,176		)	(1,866		)	Tax benefit
	Net of tax		$	2,144		$	3,294
	Foreign Currency
	Foreign currency gain		(340		)	--			Miscellaneous, net
	Total before tax		(340		)	--
			--			--			Tax benefit
	Net of tax		$	(340	)	$	--
	Other
	Changes in treasury locks		28			60			Interest Expense
	Total before tax		28			60
			(10		)	(21		)	Tax benefit
	Net of tax		$	18		$	39
	Total reclassifications for the period		$	1,822		$	3,333
		(b)		These accumulated other comprehensive income components are included in the computation of net periodic benefit costs, net of tax (see Note 5 – Retirement and Deferred Compensation Plans for additional details)

DERIVATIVE_INSTRUMENTS_AND_HED1

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)	9 Months Ended
	Sep. 30, 2014
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	'
Schedule of Fair Value of Derivative Instruments in the Condensed Consolidated Balance Sheets	'
	Derivative Contracts Not Designated	Balance Sheet		September			December
	as Hedging Instruments	Location		30, 2014			31, 2013
	Derivative Assets
	Foreign Exchange Contracts	Prepaid and other		$	801		$	3,003
	Foreign Exchange Contracts	Miscellaneous Other Assets		62			985
				$	863		$	3,988
	Derivative Liabilities
	Foreign Exchange Contracts	Accounts payable and accrued liabilities		$	3,044		$	522
	Foreign Exchange Contracts	Deferred and other non-current liabilities		345			110
				$	3,389		$	632
Effect of Derivative Instruments on the Condensed Consolidated Statements of Income	'
	The Effect of Derivative Instruments on the Condensed Consolidated Statements of Income
	for the Quarters Ended September 30, 2014 and September 30, 2013
	Derivatives Not Designated as	Location of (Loss) or Gain Recognized in		Amount of (Loss) or Gain
	Hedging Instruments	Income on Derivative		Recognized in Income on
				Derivative
				2014			2013
	Foreign Exchange Contracts	Other Income (Expense) Miscellaneous, net		$	(1,965	)	$	2,894
				$	(1,965	)	$	2,894
	The Effect of Derivative Instruments on the Condensed Consolidated Statements of Income
	for the Nine Months Ended September 30, 2014 and September 30, 2013
	Derivatives Not Designated as	Location of (Loss) or Gain Recognized in		Amount of (Loss) or Gain
	Hedging Instruments	Income on Derivative		Recognized in Income on
				Derivative
				2014			2013
	Foreign Exchange Contracts	Other Income (Expense) Miscellaneous, net		$	(3,459	)	$	2,851
				$	(3,459	)	$	2,851
Schedule of offsetting derivative assets and liabilities	'
							Net Amounts		Gross Amounts not Offset in the
					Gross Amounts		Presented in		Statement of Financial Position
		Gross			Offset in the		the Statement of		Financial	Cash Collateral	Net
		Amount			Financial Position		Financial Position		Instruments	Received	Amount
	Description
	September 30, 2014
	Derivative Assets	$	863		--		$	863	--	--	$	863
	Total Assets	$	863		--		$	863	--	--	$	863
	Derivative Liabilities	$	3,389		--		$	3,389	--	--	$	3,389
	Total Liabilities	$	3,389		--		$	3,389	--	--	$	3,389
	December 31, 2013
	Derivative Assets	$	3,988		--		$	3,988	--	--	$	3,988
	Total Assets	$	3,988		--		$	3,988	--	--	$	3,988
	Derivative Liabilities	$	632		--		$	632	--	--	$	632
	Total Liabilities	$	632		--		$	632	--	--	$	632

FAIR_VALUE_Tables

FAIR VALUE (Tables)	9 Months Ended
	Sep. 30, 2014
FAIR VALUE	'
Schedule of fair values of financial assets and liabilities	'
	As of September 30, 2014, the fair values of our financial assets and liabilities were categorized as follows:
			Total		Level 1		Level 2		Level 3
	Assets
	Forward exchange contracts (a)		$	863	$	--	$	863	$	--
	Total assets at fair value		$	863	$	--	$	863	$	--
	Liabilities
	Forward exchange contracts (a)		$	3,389	$	--	$	3,389	$	--
	Total liabilities at fair value		$	3,389	$	--	$	3,389	$	--
	As of December 31, 2013, the fair values of our financial assets and liabilities were categorized as follows:
			Total		Level 1		Level 2		Level 3
	Assets
	Forward exchange contracts (a)		$	3,988	$	--	$	3,988	$	--
	Total assets at fair value		$	3,988	$	--	$	3,988	$	--
	Liabilities
	Forward exchange contracts (a)		$	632	$	--	$	632	$	--
	Total liabilities at fair value		$	632	$	--	$	632	$	--
		(a)		Market approach valuation technique based on observable market transactions of spot and forward rates

STOCKBASED_COMPENSATION_Tables

STOCK-BASED COMPENSATION (Tables)	9 Months Ended
	Sep. 30, 2014
STOCK-BASED COMPENSATION	'
Weighted-average assumptions used to estimate fair value of stock options granted	'
	Stock Awards Plans:
	Nine months ended September 30,	2014		2013
	Dividend Yield	1.7	%	1.8	%
	Expected Stock Price Volatility	22.1	%	22.7	%
	Risk-free Interest Rate	2.3	%	1.3	%
	Expected Life of Option (years)	6.9		6.9
	The fair value of stock options granted under the Director Stock Option Plan was $14.07 and $10.89 per share during the first nine months of 2014 and 2013, respectively.  These values were estimated on the respective dates of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:
	Director Stock Option Plans:
	Nine months ended September 30,	2014		2013
	Dividend Yield	1.8	%	1.9	%
	Expected Stock Price Volatility	22.2	%	23.0	%
	Risk-free Interest Rate	2.2	%	1.3	%
	Expected Life of Option (years)	6.9		6.9
Summary of option activity	'
		Stock Awards Plans					Director Stock Option Plans
					Weighted Average					Weighted Average
		Shares			Exercise Price		Shares			Exercise Price
	Outstanding, January 1, 2014	7,815,932			$	41.26	313,834			$	48.85
	Granted	1,379,850			67.93		95,000			66.59
	Exercised	(665,671		)	32.23		(40,166		)	47.96
	Forfeited or expired	(31,417		)	49.86		--			--
	Outstanding at September 30, 2014	8,498,694			$	46.27	368,668			$	53.52
	Exercisable at September 30, 2014	5,832,623			$	39.94	188,159			$	45.98
	Weighted-Average Remaining Contractual Term (Years):
	Outstanding at September 30, 2014	6.1					7.5
	Exercisable at September 30, 2014	5					6.1
	Aggregate Intrinsic Value:
	Outstanding at September 30, 2014	$	132,612				$	3,208
	Exercisable at September 30, 2014	$	121,124				$	2,769
	Intrinsic Value of Options Exercised During the Nine Months Ended:
	September 30, 2014	$	22,386				$	741
	September 30, 2013	$	33,123				$	732
Summary of restricted stock unit activity	'
				Weighted-Average
		Shares		Grant-Date Fair Value
	Nonvested at January 1, 2014	25,681		$	53.49
	Granted	47,671		67.08
	Vested	(11,602	)	52.96
	Nonvested at September 30, 2014	61,750		$	64.09

EARNINGS_PER_SHARE_Table

EARNINGS PER SHARE (Table)	9 Months Ended
	Sep. 30, 2014
EARNINGS PER SHARE	'
Information related to the calculation of earnings per share	'
		Three months ended
		September 30, 2014				September 30, 2013
		Diluted		Basic		Diluted		Basic
	Consolidated operations
	Income available to common stockholders	$	48,595	$	48,595	$	45,264	$	45,264
	Average equivalent shares
	Shares of common stock	64,886		64,886		66,092		66,092
	Effect of dilutive stock based compensation
	Stock options	1,953		--		1,887		--
	Restricted stock units	6		--		7		--
	Total average equivalent shares	66,845		64,886		67,986		66,092
	Net income per share	$	0.73	$	0.75	$	0.67	$	0.68
		Nine months ended
		September 30, 2014				September 30, 2013
		Diluted		Basic		Diluted		Basic
	Consolidated operations
	Income available to common stockholders	$	150,060	$	150,060	$	135,095	$	135,095
	Average equivalent shares
	Shares of common stock	65,225		65,225		66,222		66,222
	Effect of dilutive stock based compensation
	Stock options	2,505		--		2,041		--
	Restricted stock units	31		--		10		--
	Total average equivalent shares	67,761		65,225		68,273		66,222
	Net income per share	$	2.21	$	2.30	$	1.98	$	2.04

SEGMENT_INFORMATION_Tables

SEGMENT INFORMATION (Tables)	9 Months Ended
	Sep. 30, 2014
SEGMENT INFORMATION	'
Financial information regarding the Company's reportable segments	'
			Three Months Ended September 30,						Nine Months Ended September 30,
			2014			2013			2014			2013
	Total Revenue:
	Beauty + Home		$	384,604		$	379,250		$	1,174,359		$	1,125,261
	Pharma		179,191			172,360			569,230			524,248
	Food + Beverage		94,118			75,531			274,936			244,434
	Total Revenue		657,913			627,141			2,018,525			1,893,943
	Less: Intersegment Sales:
	Beauty + Home		$	5,699		$	3,199		$	18,992		$	10,754
	Pharma		--			90			--			178
	Food + Beverage		272			208			909			293
	Total Intersegment Sales		$	5,971		$	3,497		$	19,901		$	11,225
	Net Sales:
	Beauty + Home		$	378,905		$	376,051		$	1,155,367		$	1,114,507
	Pharma		179,191			172,270			569,230			524,070
	Food + Beverage		93,846			75,323			274,027			244,141
	Net Sales		$	651,942		$	623,644		$	1,998,624		$	1,882,718
	Segment Income:
	Beauty + Home		$	25,399		$	30,943		$	80,378		$	85,697
	Pharma		49,314			44,737			154,589			141,154
	Food + Beverage		11,713			7,688			33,209			28,102
	Restructuring Initiatives and
	Related Depreciation (1)		--			(2,664		)	--			(10,257		)
	Corporate & Other		(8,364		)	(8,113		)	(28,664		)	(27,605		)
	Income before interest and taxes		$	78,062		$	72,591		$	239,512		$	217,091
	Interest expense, net		(3,946		)	(4,265		)	(12,010		)	(13,093		)
	Income before income taxes		$	74,116		$	68,326		$	227,502		$	203,998
		-1		Restructuring Initiatives and Related Depreciation includes the following income/(expense) items for the three and nine months ended September 30, 2014:
Restructuring Initiatives and Related Depreciation Expense	'
			Three Months Ended September 30,						Nine Months Ended September 30,
			2014			2013			2014			2013
	European Restructuring Plan
	Depreciation		$	--		$	484		$	--		$	1,499
	Employee Severance and Other Costs		--			2,180			--			8,802
	Prior Year Initiatives		--			--			--			(44		)
	Total Restructuring Initiatives and Related Depreciation Expense		$	--		$	2,664		$	--		$	10,257
	Restructuring Initiatives and Related Depreciation Expense by Segment
	Beauty + Home		$	--		$	2,664		$	--		$	10,280
	Pharma		--			--			--			--
	Food + Beverage		--			--			--			(23		)
	Total Restructuring Initiatives and Related Depreciation Expense		$	--		$	2,664		$	--		$	10,257

RESTRUCTURING_INITIATIVE_Table

RESTRUCTURING INITIATIVE (Tables) (European Restructuring Plan)	9 Months Ended
	Sep. 30, 2014
European Restructuring Plan	'
Restructuring initiative	'
Activity associated with the entity's restructuring initiatives	'
		Beginning		Net Charges for								Ending
		Reserve at		the Nine Months								Reserve at
		12/31/13		Ended 9/30/14		Cash Paid			FX Impact			9/30/14
	Employee severance	$	2,521	$	--	$	(1,933	)	$	(158	)	$	430
	Other costs	1,735		--		(1,568		)	(82		)	85
	Totals	$	4,256	$	--	$	(3,501	)	$	(240	)	$	515

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2014
INCOME TAXES	'	'
Tax cost of repatriation included in effective tax rate	'	$0
Expected distribution of foreign earnings	'	0
Additional tax cost expected to be generated on distribution of dividends	3,100,000	'
Additional tax cost expected to be generated on distribution of dividends related to change in reinvestment assetion within Europe	$2,800,000	'

INVENTORIES_Details

INVENTORIES (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
INVENTORIES	'	'
Inventories accounted for by using the LIFO method (as a percent)	19.00%	20.00%
Inventories, by component	'	'
Raw materials	$115,575	$114,501
Work in process	103,262	108,924
Finished goods	130,055	137,591
Total	348,892	361,016
Less LIFO reserve	-7,940	-7,857
Total	$340,952	$353,159

GOODWILL_AND_OTHER_INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Changes in the carrying amount of goodwill	'	'
Goodwill	$340,890	$360,480
Accumulated impairment losses	-1,615	-1,615
Goodwill, balance at the beginning of the period	358,865	'
Foreign currency exchange effects	-19,590	'
Goodwill, balance at the end of the period	339,275	'
Operating segment | Beauty + Home	'	'
Changes in the carrying amount of goodwill	'	'
Goodwill	174,428	181,002
Goodwill, balance at the beginning of the period	181,002	'
Foreign currency exchange effects	-6,574	'
Goodwill, balance at the end of the period	174,428	'
Operating segment | Pharma	'	'
Changes in the carrying amount of goodwill	'	'
Goodwill	147,566	159,949
Goodwill, balance at the beginning of the period	159,949	'
Foreign currency exchange effects	-12,383	'
Goodwill, balance at the end of the period	147,566	'
Operating segment | Food + Beverage	'	'
Changes in the carrying amount of goodwill	'	'
Goodwill	17,281	17,914
Goodwill, balance at the beginning of the period	17,914	'
Foreign currency exchange effects	-633	'
Goodwill, balance at the end of the period	17,281	'
Corporate Non-Segment	'	'
Changes in the carrying amount of goodwill	'	'
Goodwill	1,615	1,615
Accumulated impairment losses	($1,615)	($1,615)

GOODWILL_AND_OTHER_INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS (Details 2) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Amortized intangible assets:	'	'	'	'	'
Gross Carrying Amount	$89,032	'	$89,032	'	$95,970
Accumulated Amortization	-46,481	'	-46,481	'	-46,019
Net Value	42,551	'	42,551	'	49,951
Aggregate amortization expense	1,283	1,266	4,050	3,748	'
Future estimated amortization expense	'	'	'	'	'
2014	1,291	'	1,291	'	'
2015	4,960	'	4,960	'	'
2016	4,024	'	4,024	'	'
2017	3,338	'	3,338	'	'
2018 and thereafter	28,938	'	28,938	'	'
Weighted Average	'	'	'	'	'
Amortized intangible assets:	'	'	'	'	'
Amortization Period	'	'	'10 years	'	'
Patents	'	'	'	'	'
Amortized intangible assets:	'	'	'	'	'
Gross Carrying Amount	18,282	'	18,282	'	20,165
Accumulated Amortization	-18,067	'	-18,067	'	-19,732
Net Value	215	'	215	'	433
Patents | Weighted Average	'	'	'	'	'
Amortized intangible assets:	'	'	'	'	'
Amortization Period	'	'	'7 years	'	'
Acquired technology	'	'	'	'	'
Amortized intangible assets:	'	'	'	'	'
Gross Carrying Amount	37,260	'	37,260	'	40,546
Accumulated Amortization	-5,589	'	-5,589	'	-4,055
Net Value	31,671	'	31,671	'	36,491
Acquired technology | Weighted Average	'	'	'	'	'
Amortized intangible assets:	'	'	'	'	'
Amortization Period	'	'	'15 years	'	'
License agreements and other	'	'	'	'	'
Amortized intangible assets:	'	'	'	'	'
Gross Carrying Amount	33,490	'	33,490	'	35,259
Accumulated Amortization	-22,825	'	-22,825	'	-22,232
Net Value	$10,665	'	$10,665	'	$13,027
License agreements and other | Weighted Average	'	'	'	'	'
Amortized intangible assets:	'	'	'	'	'
Amortization Period	'	'	'5 years	'	'

INCOME_TAXES_UNCERTAINTIES_Det

INCOME TAXES UNCERTAINTIES (Details) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
INCOME TAX UNCERTAINTIES	'	'
Income tax uncertainties	$6.60	$8
Change in income tax uncertainties	1.4	'
Amount of income tax uncertainties that, if recognized, would impact the effective tax rate	6.4	7.8
Decrease in liability for uncertain tax positions, high end of range	$5	'
Number of months, in which liability for uncertain tax positions will decrease	'12 months	'

RETIREMENT_AND_DEFERRED_COMPEN2

RETIREMENT AND DEFERRED COMPENSATION PLANS (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Domestic Plans	'	'	'	'
Components of net periodic benefit cost:	'	'	'	'
Service cost	$2,011,000	$2,135,000	$6,032,000	$6,405,000
Interest cost	1,482,000	1,248,000	4,446,000	3,744,000
Expected return on plan assets	-1,647,000	-1,443,000	-4,939,000	-4,331,000
Amortization of net loss	718,000	1,276,000	2,152,000	3,827,000
Amortization of prior service cost	'	'	'	2,000
Net periodic benefit cost	2,564,000	3,216,000	7,691,000	9,647,000
Minimum funding requirement	'	'	0	'
Employer contributions	10,000,000	'	10,000,000	'
Foreign Plans	'	'	'	'
Components of net periodic benefit cost:	'	'	'	'
Service cost	1,043,000	974,000	3,203,000	2,902,000
Interest cost	676,000	668,000	2,074,000	1,991,000
Expected return on plan assets	-494,000	-454,000	-1,514,000	-1,353,000
Amortization of net loss	303,000	353,000	929,000	1,053,000
Amortization of prior service cost	78,000	93,000	239,000	278,000
Net periodic benefit cost	1,606,000	1,634,000	4,931,000	4,871,000
Expected contribution in current fiscal year	'	'	5,600,000	'
Employer contributions	'	'	$2,000,000	'

ACCUMULATED_OTHER_COMPREHENSIV2

ACCUMULATED OTHER COMPREHENSIVE INCOME (Details) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Accumulated other comprehensive income activity	'	'
Balance at the beginning of the period	$109,751	$60,683
Other comprehensive income (loss) before reclassifications	-123,014	16,275
Amounts reclassified from accumulated other comprehensive income	1,822	3,333
Net current-period other comprehensive (loss) income	-121,192	19,608
Balance at the end of the period	-11,441	80,291
Foreign Currency	'	'
Accumulated other comprehensive income activity	'	'
Balance at the beginning of the period	149,965	120,097
Other comprehensive income (loss) before reclassifications	-123,014	16,275
Amounts reclassified from accumulated other comprehensive income	-340	'
Net current-period other comprehensive (loss) income	-123,354	16,275
Balance at the end of the period	26,611	136,372
Defined Benefit Pension Plans	'	'
Accumulated other comprehensive income activity	'	'
Balance at the beginning of the period	-40,093	-59,248
Amounts reclassified from accumulated other comprehensive income	2,144	3,294
Net current-period other comprehensive (loss) income	2,144	3,294
Balance at the end of the period	-37,949	-55,954
Other	'	'
Accumulated other comprehensive income activity	'	'
Balance at the beginning of the period	-121	-166
Amounts reclassified from accumulated other comprehensive income	18	39
Net current-period other comprehensive (loss) income	18	39
Balance at the end of the period	($103)	($127)

ACCUMULATED_OTHER_COMPREHENSIV3

ACCUMULATED OTHER COMPREHENSIVE INCOME (Details 2) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Amount Reclassified from Accumulated Other Comprehensive Income	'	'	'	'
Interest expense	$5,332	$4,841	$15,459	$15,364
Miscellaneous, net	429	437	582	1,070
Total before tax	-74,116	-68,326	-227,502	-203,998
Tax benefit	25,496	23,094	77,390	68,908
Total reclassifications for the period	-48,595	-45,264	-150,060	-135,095
Amount Reclassified from Accumulated Other Comprehensive Income	'	'	'	'
Amount Reclassified from Accumulated Other Comprehensive Income	'	'	'	'
Total reclassifications for the period	715	1,109	1,822	3,333
Defined Benefit Pension Plans | Amount Reclassified from Accumulated Other Comprehensive Income	'	'	'	'
Amount Reclassified from Accumulated Other Comprehensive Income	'	'	'	'
Amortization of net loss	1,021	1,629	3,081	4,880
Amortization of prior service cost	78	93	239	280
Total before tax	1,099	1,722	3,320	5,160
Tax benefit	-390	-622	-1,176	-1,866
Total reclassifications for the period	709	1,100	2,144	3,294
Foreign Currency | Amount Reclassified from Accumulated Other Comprehensive Income	'	'	'	'
Amount Reclassified from Accumulated Other Comprehensive Income	'	'	'	'
Miscellaneous, net	'	'	-340	'
Total before tax	'	'	-340	'
Total reclassifications for the period	'	'	-340	'
Other | Treasury locks | Amount Reclassified from Accumulated Other Comprehensive Income	'	'	'	'
Amount Reclassified from Accumulated Other Comprehensive Income	'	'	'	'
Interest expense	9	14	28	60
Total before tax	9	14	28	60
Tax benefit	-3	-5	-10	-21
Total reclassifications for the period	$6	$9	$18	$39

DERIVATIVE_INSTRUMENTS_AND_HED2

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	'	'
Aggregate amount of forward exchange contracts, outstanding	$155,000,000	'
Fair Value of Derivative Instruments	'	'
Derivative Assets	863,000	3,988,000
Derivative Liabilities	3,389,000	632,000
Derivative Contracts Not Designated as Hedging Instruments	'	'
Fair Value of Derivative Instruments	'	'
Derivative Assets	863,000	3,988,000
Derivative Liabilities	3,389,000	632,000
Derivative Contracts Not Designated as Hedging Instruments | Foreign Exchange Contracts | Prepaid and other	'	'
Fair Value of Derivative Instruments	'	'
Derivative Assets	801,000	3,003,000
Derivative Contracts Not Designated as Hedging Instruments | Foreign Exchange Contracts | Miscellaneous Other Assets	'	'
Fair Value of Derivative Instruments	'	'
Derivative Assets	62,000	985,000
Derivative Contracts Not Designated as Hedging Instruments | Foreign Exchange Contracts | Accounts payable and accrued liabilities	'	'
Fair Value of Derivative Instruments	'	'
Derivative Liabilities	3,044,000	522,000
Derivative Contracts Not Designated as Hedging Instruments | Foreign Exchange Contracts | Deferred and other non-current liabilities	'	'
Fair Value of Derivative Instruments	'	'
Derivative Liabilities	$345,000	$110,000

DERIVATIVE_INSTRUMENTS_AND_HED3

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details 2) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Derivative instruments, gain or (loss)	'	'	'	'
Foreign Exchange Contract, Amount of Gain (Loss) Recognized in Income on Derivative, not designated as hedging instruments	($1,965)	$2,894	($3,459)	$2,851
Foreign Exchange Contracts	'	'	'	'
Derivative instruments, gain or (loss)	'	'	'	'
Foreign Exchange Contract, Amount of Gain (Loss) Recognized in Income on Derivative, not designated as hedging instruments	($1,965)	$2,894	($3,459)	$2,851

DERIVATIVE_INSTRUMENTS_AND_HED4

DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Details 3) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Derivative Assets	'	'
Gross Amount	$863	$3,988
Net Amounts Presented in the Statement of Financial Position	863	3,988
Net Amount	863	3,988
Derivative Liabilities	'	'
Gross Amount	3,389	632
Net Amounts Presented in the Statement of Financial Position	3,389	632
Net Amount	$3,389	$632

FAIR_VALUE_Details

FAIR VALUE (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Liabilities	'	'
Fair value of long-term obligations	$370,000,000	$363,000,000
Assets and liabilities measured at fair value on recurring basis | Total	'	'
Assets	'	'
Forward exchange contracts, assets	863,000	3,988,000
Total assets at fair value	863,000	3,988,000
Liabilities	'	'
Forward exchange contracts, liabilities	3,389,000	632,000
Total liabilities at fair value	3,389,000	632,000
Assets and liabilities measured at fair value on recurring basis | Level 2	'	'
Assets	'	'
Forward exchange contracts, assets	863,000	3,988,000
Total assets at fair value	863,000	3,988,000
Liabilities	'	'
Forward exchange contracts, liabilities	3,389,000	632,000
Total liabilities at fair value	$3,389,000	$632,000

STOCK_REPURCHASE_PROGRAM_Detai

STOCK REPURCHASE PROGRAM (Details) (USD $)	0 Months Ended	3 Months Ended	9 Months Ended
	Oct. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2013
STOCK REPURCHASE PROGRAM	'	'	'	'
Number of shares repurchased	'	600,000	1,400,000	'
Aggregate amount of share repurchases (in dollars)	'	$37,600,000	$90,517,000	$80,222,000
Remaining authorization to repurchase additional shares	'	2,600,000	2,600,000	'
Share repurchases authorized amount	$350,000,000	'	'	'

STOCKBASED_COMPENSATION_Detail

STOCK-BASED COMPENSATION (Details) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
STOCK-BASED COMPENSATION	'	'
Proceeds from stock option exercises	$24,564,000	$38,368,000
Stock options	'	'
STOCK-BASED COMPENSATION	'	'
Award vesting period	'3 years	'
Expiration period	'10 years	'
Compensation expense	15,000,000	11,500,000
Compensation expense, net of tax	9,800,000	7,700,000
Income tax benefit related to compensation expense	5,200,000	3,800,000
Weighted-average fair value of stock options granted (in dollars per share)	$14.82	$10.16
Fair value of shares vested	14,100,000	12,900,000
Proceeds from stock option exercises	24,600,000	'
Actual tax benefit realized for the tax deduction from option exercises	7,000,000	'
Unrecognized compensation cost expected to be recognized in future periods	16,100,000	'
Weighted-average period over which compensation cost is expected to be recognized	'1 year 6 months	'
Stock options | Selling, research & development and administrative expenses	'	'
STOCK-BASED COMPENSATION	'	'
Compensation expense	13,400,000	10,200,000
Stock Awards Plans | Stock options	'	'
Assumptions used to estimate fair value of stock options granted	'	'
Dividend Yield (as a percent)	1.70%	1.80%
Expected Stock Price Volatility (as a percent)	22.10%	22.70%
Risk-free Interest Rate (as a percent)	2.30%	1.30%
Expected Life of Option	'6 years 10 months 24 days	'6 years 10 months 24 days
Stock options activity	'	'
Outstanding at the beginning of the period (in shares)	7,815,932	'
Granted (in shares)	1,379,850	'
Exercised (in shares)	-665,671	'
Forfeited or expired (in shares)	-31,417	'
Outstanding at the end of the period (in shares)	8,498,694	'
Exercisable at the end of the period (in shares)	5,832,623	'
Weighted Average Exercise Price	'	'
Outstanding at the beginning of the period (in dollars per share)	$41.26	'
Granted (in dollars per share)	$67.93	'
Exercised (in dollars per share)	$32.23	'
Forfeited or expired (in dollars per share)	$49.86	'
Outstanding at the end of the period (in dollars per share)	$46.27	'
Exercisable at the end of the period (in dollars per share)	$39.94	'
Weighted-Average Remaining Contractual Term (Years):	'	'
Outstanding at the end of the period	'6 years 1 month 6 days	'
Exercisable at the end of the period	'5 years	'
Aggregate Intrinsic Value:	'	'
Outstanding at the end of the period	132,612,000	'
Exercisable at the end of the period	121,124,000	'
Intrinsic Value of Options Exercised	22,386,000	33,123,000
Stock Awards Plans | Restricted stock units	'	'
STOCK-BASED COMPENSATION	'	'
Award vesting period	'3 years	'
Compensation expense	1,400,000	574,000
Unrecognized compensation cost expected to be recognized in future periods	2,300,000	'
Weighted-average period over which compensation cost is expected to be recognized	'1 year 7 months 6 days	'
Restricted stock unit activity	'	'
Balance at the beginning of the period (in shares)	25,681	'
Granted (in shares)	47,671	'
Vested (in shares)	-11,602	'
Balance at the end of the period (in shares)	61,750	'
Weighted-Average Grant-Date Fair Value	'	'
Nonvested at the beginning of the period (in dollars per share)	$53.49	'
Granted (in dollars per share)	$67.08	'
Vested (in dollars per share)	$52.96	'
Nonvested at the end of the period (in dollars per share)	$64.09	'
Fair value of units vested	614,000	571,000
Intrinsic value of units vested	761,000	661,000
Director Stock Option Plans | Stock options	'	'
STOCK-BASED COMPENSATION	'	'
Weighted-average fair value of stock options granted (in dollars per share)	$14.07	$10.89
Assumptions used to estimate fair value of stock options granted	'	'
Dividend Yield (as a percent)	1.80%	1.90%
Expected Stock Price Volatility (as a percent)	22.20%	23.00%
Risk-free Interest Rate (as a percent)	2.20%	1.30%
Expected Life of Option	'6 years 10 months 24 days	'6 years 10 months 24 days
Stock options activity	'	'
Outstanding at the beginning of the period (in shares)	313,834	'
Granted (in shares)	95,000	'
Exercised (in shares)	-40,166	'
Outstanding at the end of the period (in shares)	368,668	'
Exercisable at the end of the period (in shares)	188,159	'
Weighted Average Exercise Price	'	'
Outstanding at the beginning of the period (in dollars per share)	$48.85	'
Granted (in dollars per share)	$66.59	'
Exercised (in dollars per share)	$47.96	'
Outstanding at the end of the period (in dollars per share)	$53.52	'
Exercisable at the end of the period (in dollars per share)	$45.98	'
Weighted-Average Remaining Contractual Term (Years):	'	'
Outstanding at the end of the period	'7 years 6 months	'
Exercisable at the end of the period	'6 years 1 month 6 days	'
Aggregate Intrinsic Value:	'	'
Outstanding at the end of the period	3,208,000	'
Exercisable at the end of the period	2,769,000	'
Intrinsic Value of Options Exercised	741,000	732,000
New long-term incentive program	'	'
STOCK-BASED COMPENSATION	'	'
Compensation expense	480,000	'
Performance period used to measure cumulative total shareholder return of common stock	'3 years	'
Expected total expense related to program over the performance period	$1,200,000	'

EARNINGS_PER_SHARE_Details

EARNINGS PER SHARE (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
EARNINGS PER SHARE	'	'	'	'	'
Authorized common stock (in shares)	199,000,000	'	199,000,000	'	199,000,000
Common stock, par value (in dollars per share)	$0.01	'	$0.01	'	$0.01
Diluted	'	'	'	'	'
Income available to common stockholders (in dollars)	$48,595	$45,264	$150,060	$135,095	'
Shares of common stock	64,886,000	66,092,000	65,225,000	66,222,000	'
Total average equivalent shares	66,845,000	67,986,000	67,761,000	68,273,000	'
Net income per share, diluted (in dollars per share)	$0.73	$0.67	$2.21	$1.98	'
Basic	'	'	'	'	'
Income available to common stockholders (in dollars)	$48,595	$45,264	$150,060	$135,095	'
Shares of common stock	64,886,000	66,092,000	65,225,000	66,222,000	'
Net income per share, basic (in dollars per share)	$0.75	$0.68	$2.30	$2.04	'
Stock options	'	'	'	'	'
Diluted	'	'	'	'	'
Effect of dilutive stock based compensation (in shares)	1,953,000	1,887,000	2,505,000	2,041,000	'
Restricted stock units	'	'	'	'	'
Diluted	'	'	'	'	'
Effect of dilutive stock based compensation (in shares)	6,000	7,000	31,000	10,000	'

SEGMENT_INFORMATION_Details

SEGMENT INFORMATION (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
			segment
SEGMENT INFORMATION	'	'	'	'
Number of reportable segments	'	'	3	'
Financial information regarding the Company's reportable segments	'	'	'	'
Net Sales	$651,942	$623,644	$1,998,624	$1,882,718
Income before interest and taxes	78,062	72,591	239,512	217,091
Interest expense, net	-3,946	-4,265	-12,010	-13,093
Income before Income Taxes	74,116	68,326	227,502	203,998
Restructuring Initiatives and Related Depreciation Expense by Segment	'	'	'	'
Employee Severance and Other Costs	'	2,180	'	8,758
Total Restructuring Initiatives and Related Depreciation expense	'	2,664	'	10,257
Restructuring Initiatives	'	'	'	'
Financial information regarding the Company's reportable segments	'	'	'	'
Income before interest and taxes	'	-2,664	'	-10,257
Prior Year Initiatives	'	'	'	'
Restructuring Initiatives and Related Depreciation Expense by Segment	'	'	'	'
Employee Severance and Other Costs	'	'	'	-44
European Restructuring Plan	'	'	'	'
Restructuring Initiatives and Related Depreciation Expense by Segment	'	'	'	'
Depreciation	'	484	'	1,499
Employee Severance and Other Costs	'	2,180	'	8,802
Beauty + Home	'	'	'	'
Financial information regarding the Company's reportable segments	'	'	'	'
Net Sales	378,905	376,051	1,155,367	1,114,507
Income before interest and taxes	25,399	30,943	80,378	85,697
Beauty + Home | Restructuring	'	'	'	'
Restructuring Initiatives and Related Depreciation Expense by Segment	'	'	'	'
Total Restructuring Initiatives and Related Depreciation expense	'	2,664	'	10,280
Pharma	'	'	'	'
Financial information regarding the Company's reportable segments	'	'	'	'
Net Sales	179,191	172,270	569,230	524,070
Income before interest and taxes	49,314	44,737	154,589	141,154
Food + Beverage	'	'	'	'
Financial information regarding the Company's reportable segments	'	'	'	'
Net Sales	93,846	75,323	274,027	244,141
Income before interest and taxes	11,713	7,688	33,209	28,102
Food + Beverage | Restructuring	'	'	'	'
Restructuring Initiatives and Related Depreciation Expense by Segment	'	'	'	'
Total Restructuring Initiatives and Related Depreciation expense	'	'	'	-23
Corporate & Other	'	'	'	'
Financial information regarding the Company's reportable segments	'	'	'	'
Income before interest and taxes	-8,364	-8,113	-28,664	-27,605
Operating segment	'	'	'	'
Financial information regarding the Company's reportable segments	'	'	'	'
Net Sales	657,913	627,141	2,018,525	1,893,943
Operating segment | Beauty + Home	'	'	'	'
Financial information regarding the Company's reportable segments	'	'	'	'
Net Sales	384,604	379,250	1,174,359	1,125,261
Operating segment | Pharma	'	'	'	'
Financial information regarding the Company's reportable segments	'	'	'	'
Net Sales	179,191	172,360	569,230	524,248
Operating segment | Food + Beverage	'	'	'	'
Financial information regarding the Company's reportable segments	'	'	'	'
Net Sales	94,118	75,531	274,936	244,434
Intersegment	'	'	'	'
Financial information regarding the Company's reportable segments	'	'	'	'
Net Sales	5,971	3,497	19,901	11,225
Intersegment | Beauty + Home	'	'	'	'
Financial information regarding the Company's reportable segments	'	'	'	'
Net Sales	5,699	3,199	18,992	10,754
Intersegment | Pharma	'	'	'	'
Financial information regarding the Company's reportable segments	'	'	'	'
Net Sales	'	90	'	178
Intersegment | Food + Beverage	'	'	'	'
Financial information regarding the Company's reportable segments	'	'	'	'
Net Sales	$272	$208	$909	$293

NONRECURRING_EVENTS_Details

NONRECURRING EVENTS (Details) (Graphocolor, USD $)	3 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014
Graphocolor	'
NONRECURRING EVENTS	'
Costs related to fire	$3.70
Gain contingencies recognized	$0

ACQUISITIONS_Details

ACQUISITIONS (Details) (Bapco, USD $)	1 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013
Bapco	'
Acquisitions	'
Percentage of interest acquired	20.00%
Payment to acquire business	$5.20

RESTRUCTURING_INITIATIVE_Detai

RESTRUCTURING INITIATIVE (Details) (European Restructuring Plan, USD $)	1 Months Ended	9 Months Ended
	Nov. 30, 2012	Sep. 30, 2014
	item
Restructuring initiative	'	'
Number of facilities involved in restructuring plan	12	'
Number of facilities closed	2	'
Number of employees impacted by closure of facilities	170	'
Cumulative expense incurred to date	'	$19,500,000
Restructuring reserve	'	'
Restructuring reserve, balance at the beginning of the period	'	4,256,000
Cash Paid	'	-3,501,000
FX Impact	'	-240,000
Restructuring reserve, balance at the end of the period	'	515,000
Employee severance	'	'
Restructuring reserve	'	'
Restructuring reserve, balance at the beginning of the period	'	2,521,000
Cash Paid	'	-1,933,000
FX Impact	'	-158,000
Restructuring reserve, balance at the end of the period	'	430,000
Other costs	'	'
Restructuring reserve	'	'
Restructuring reserve, balance at the beginning of the period	'	1,735,000
Cash Paid	'	-1,568,000
FX Impact	'	-82,000
Restructuring reserve, balance at the end of the period	'	$85,000